Huntsworth
Huntsworth makes European strategy appointment
September 3, 2010Medical Communications Huntsworth, appointment, medical communications
UK communications company Huntsworth Health has appointed Annabelle Sandeman as European Director Strategic Development. She will report to chief executive …
Tonic Life expands into Asia
July 23, 2010Medical Communications Huntsworth, Tonic
Tonic Life Communications has opened an office in Hong Kong as the first step in regional expansion plans that will …
Huntsworth acquires ScopeMedical
July 12, 2010Medical Communications Huntsworth, ScopeMedical
UK communications group Huntsworth has acquired ScopeMedical in a deal that could be worth up to £11 million. The Kent-based …
Sandy Royden steps down from Huntsworth
February 9, 2010Medical Communications Huntsworth, appointment, medical communications
Huntsworth Health’s European chief executive Sandy Royden is stepping down at the end of March. Sandy, who is expecting a …
Huntsworth reorganises European health offering
February 9, 2010Medical Communications Huntsworth
Huntsworth Health has completed a reshuffle of its European operations that sees the company align its operations under three brands. …
Huntsworth Health reshuffles global operations
October 15, 2009Medical Communications Huntsworth, Tonic
Healthcare marketing and communications agency Huntsworth Health is reorganising its global operations.Part of Huntsworth plc, it will be split into …
Tonic to join Huntsworth group as global PR brand
July 20, 2009Medical Communications, Sales and Marketing Huntsworth, Tonic
Independent public relations and communications agency Tonic has been acquired by the Huntsworth group.The Huntsworth group has grown rapidly over …
Merck Serono picks Huntsworth for infertility work
January 26, 2007Medical Communications Huntsworth
Newly merged biopharmaceutical company Merck Serono has awarded Huntsworth Health the UK account for one of biggest selling drugs.The agency …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
